---
title: "諾和諾德哥本哈根股價（NOVOB.DC）收跌 1.81%，報 308.80 丹麥克朗，本週累計下跌 31.70%，創公司丹麥 IPO 以來最差單週表現。同時，該公司在發佈業績報告時宣佈提拔內部高管為新"
description: "諾和諾德哥本哈根股價（NOVOB.DC）收跌 1.81%，報 308.80 丹麥克朗，本週累計下跌 31.70%，創公司丹麥 IPO 以來最差單週表現。同時，該公司在發佈業績報告時宣佈提拔內部高管為新 CEO。此外，美國總統特朗普要求醫藥公司降低美國市場藥品價格。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/251238721.md"
published_at: "2025-08-01T17:40:05.000Z"
---

# 諾和諾德哥本哈根股價（NOVOB.DC）收跌 1.81%，報 308.80 丹麥克朗，本週累計下跌 31.70%，創公司丹麥 IPO 以來最差單週表現。同時，該公司在發佈業績報告時宣佈提拔內部高管為新

> 諾和諾德哥本哈根股價（NOVOB.DC）收跌 1.81%，報 308.80 丹麥克朗，本週累計下跌 31.70%，創公司丹麥 IPO 以來最差單週表現。同時，該公司在發佈業績報告時宣佈提拔內部高管為新 CEO。此外，美國總統特朗普要求醫藥公司降低美國市場藥品價格。

諾和諾德哥本哈根股價（NOVOB.DC）收跌 1.81%，報 308.80（丹麥克朗），本週累計下跌 31.70%，創該公司丹麥 IPO 以來最差單週表現。 本週，該公司在發佈業績報告時宣佈，提拔內部高管為新 CEO。 隨後，美國總統特朗普要求眾多醫藥公司在美國市場降低藥品價格。

### Related Stocks

- [NVO.US - 諾和諾德公司](https://longbridge.com/zh-HK/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? | As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? | [Link](https://longbridge.com/zh-HK/news/270794581.md) |
| Novo Nordisk (NVO) Rethinks Pricing as Compounded GLP-1 Drugs Gain Ground | Novo Nordisk CEO Mike Doustdar announced that 1.5 million people in the U.S. are using compounded GLP-1 weight-loss drug | [Link](https://longbridge.com/zh-HK/news/272307926.md) |
| OXY-Clean: Buffett's Favourite Oil Rig Scrubs $6 Billion In Debt Off The Books | Occidental Petroleum Corp (NYSE:OXY) has significantly reduced its debt by $5.8 billion after selling its OxyChem divisi | [Link](https://longbridge.com/zh-HK/news/276372720.md) |
| Palantir spent $25M on CEO flights so Alex Karp could do all the talking | Palantir CEO Alex Karp has spent nearly $25 million on private flights over two years to maintain his visibility in the  | [Link](https://longbridge.com/zh-HK/news/276359392.md) |
| BUZZ-Street View: Booking Holdings may be shielded from AI disruption noise | Booking Holdingssurpassed Q4 profit expectations, driven by strong international travel demand. RBC Capital Markets sugg | [Link](https://longbridge.com/zh-HK/news/276333390.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。